Oracle is behind the AI demand curve, but this could spell accelerating growth and significant upside for investors.

Oracle generated $17.2 billion in total revenue during its fiscal 2026 third quarter, which was a 17% increase from the ...

Worries that fast-advancing AI tools could upend software and services pummeled stocks in the sector last month. Oracle's ...

Discover how Oracle's earnings report could influence its full-year 2026 guidance and long-term growth strategy. Read more here.

Oracle's latest earnings surpassed estimates, and remarks from executives calmed worries about the breakneck pace of AI infrastructure spending.

Oracle Corporation is rated a Buy due to robust execution, margin inflection, and high potential cloud growth opportunity.

Oracle Health launches clinical AI note tool to reduce documentation time and streamline workflows in inpatient and emergency department settings.

Oracle Corp. (NYSE:ORCL) reports strong Q3 results, with revenue of $17.19B and adjusted EPS of $1.79. Q4 revenue expected to grow 18-20%.

Oracle shares led the tech sector higher Wednesday as investors cheered the cloud giant's better-than-expected earnings and stronger outlook.

Oracle (NYSE:ORCL) reported its fiscal third-quarter 2026 results after the bell on Tuesday, March 10, and the market liked ...

Oracle (ORCL) earnings show 20% revenue growth with stable margins, strong cloud/AI backlog and upside valuation potential.

Oracle surpassed estimates for the quarter, and lifted its guidance for fiscal 2027 revenue. During the quarter, Oracle announced plans to raise $45 billion to $50 billion in the fiscal year to expand ...